Examining the link between price regulation and pharmaceutical R&D investment
Author:
Affiliation:
1. Department of Finance & Center for Healthcare & Insurance Studies, Graduate School of Business, University of Connecticut, Connecticut, USA
Publisher
Wiley
Subject
Health Policy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hec.897
Reference28 articles.
1. Making sense of drug prices;Danzon P;Regulation,2000
2. The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries
3. A New Look at the Returns and Risks to Pharmaceutical R&D
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Modeling impact of inflation reduction act price negotiations on new drug pipeline considering differential contributions of large and small biopharmaceutical companies;Clinical Trials;2024-07-24
2. Implications of the Inflation Reduction Act for the biotechnology industry; sensitivity of investment and valuation to drug price indices and market conditions;2024-06-28
3. Price regulation, network externality, and product innovation strategies: A dynamic analysis;Managerial and Decision Economics;2024-06-03
4. Timely, Cheap, or Risk-Free? The Effect of Regulation on the Price and Availability of New Drugs;Pharmacy;2024-03-18
5. Health policy, price regulation, and innovation: Evidence from China’s vaccine industry;Journal of Development Economics;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3